文献速递生殖医学

法尼基化依赖的着丝粒蛋白F着丝粒定位对卵母细胞减数分裂进程和女性生育力至关重要

Farnesylation-dependent kinetochore targeting of centromere protein F is essential for oocyte meiotic progression and female fertility.
PubMed 文献 · Am J Obstet Gynecol · 2025-08-28

本研究通过小鼠卵母细胞微注射、药理抑制和点突变等方法,揭示着丝粒蛋白F(CENP-F)的法尼基化修饰调控其着丝粒定位并与Aurora激酶B互作,从而影响减数分裂;在179例卵母细胞成熟障碍不孕患者中检出4例CENP-F突变,患者来源突变可致小鼠卵母细胞成熟率下降和纺锤体组装检查点持续激活。

要点

  • CENP-F敲低使小鼠卵母细胞成熟率从77.84%降至34.26%,多数阻滞于减数第一次分裂中期。
  • 法尼基化抑制或C3111S突变降低卵母细胞成熟率,并减弱CENP-F与Aurora激酶B的互作。
  • 179例卵母细胞成熟障碍患者中检出4例CENP-F突变,患者突变可损害CENP-F法尼基化及着丝粒定位。

核心结论

  • 本研究首次证明CENP-F基因缺陷与人类不孕直接相关,揭示法尼基化依赖的减数分裂调控新机制,并提示CENP-F可作为诊断卵母细胞成熟失败的潜在分子标志物。

研究设计与样本

  • 基础研究结合临床遗传学筛查:小鼠卵母细胞采用微注射、蛋白印迹、免疫共沉淀和免疫荧光;药理学用法尼基转移酶抑制剂,遗传学用C3111S点突变。
  • 对179例卵母细胞成熟障碍不孕患者行全外显子组测序,鉴定出4例CENP-F突变,并用小鼠卵母细胞和293T细胞模型验证突变机制。

主要发现

  • 小鼠卵母细胞注射CENP-F siRNA后成熟率显著降低(77.84±2.087% vs 34.26±4.748%,P<.01),减数第一次分裂中期阻滞比例升高(17.69±2.207% vs 44.93±5.539%,P<.05)。
  • 法尼基转移酶抑制剂处理组卵母细胞成熟率显著低于对照(75.58±3.703% vs 46.18±1.282%,P<.01);C3111S突变组也显著低于对照(75.58±3.703% vs 44.04±2.541%,P<.01),且CENP-F与Aurora激酶B互作减弱(P<.01)。
  • 注射患者来源突变CENP-F cRNA的小鼠卵母细胞成熟率显著低于对照(77.00±2.411% vs 49.10±6.561%、35.43±1.035%、55.43±1.288%、40.00±4.187%,P分别<.01、<.01、<.05、<.01)。
  • K1708T/S1971fs突变可降低CENP-F法尼基化(P<.05/P<.01)、损害其与Aurora激酶B互作(P<.05/P<.01)并破坏着丝粒定位。
  • CENP-F缺失和患者突变均诱导纺锤体组装检查点持续激活,检查点抑制剂部分挽救卵母细胞减数分裂阻滞(P<.05)。

关键数值与推荐

  • CENP-F敲低组卵母细胞成熟率为34.26±4.748%,对照组为77.84±2.087%(P<.01)。
  • 法尼基转移酶抑制剂组成熟率为46.18±1.282%,对照组为75.58±3.703%(P<.01);C3111S突变组为44.04±2.541%,对照组为75.58±3.703%(P<.01)。
  • 患者突变cRNA注射组成熟率分别为49.10±6.561%、35.43±1.035%、55.43±1.288%、40.00±4.187%,对照组为77.00±2.411%(P分别<.01、<.01、<.05、<.01)。
  • K1708T/S1971fs突变降低CENP-F法尼基化(P<.05/P<.01)并减弱与Aurora激酶B互作(P<.05/P<.01)。
  • 纺锤体组装检查点抑制剂部分挽救减数分裂阻滞(P<.05)。

临床怎么用

  • 作者认为CENP-F可作为诊断卵母细胞成熟失败的潜在分子标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During mammalian oocyte meiosis, accurate chromosome segregation critically depends on precise regulation of kinetochore-microtubule attachments, a process monitored by the spindle assembly checkpoint. While centromere protein F has been well characterized as a kinetochore-associated protein that stabilizes kinetochore-microtubule connections during mitosis, its functional mechanisms during meiosis remain poorly understood. In particular, there is still controversy over whether farnesylation modification governs localization and functionality of centromere protein F. Concurrently, clinical investigations face a knowledge gap regarding the genetic basis of oocyte maturation arrest, a prevalent phenotype observed in female infertility patients. OBJECTIVE: This study aims to reveal the regulatory mechanism of centromere protein F farnesylation modification on its meiotic function and explore the association between centromere protein F gene mutations and female oocyte maturation disorders. STUDY DESIGN: Previous studies have shown that centromere protein F is essential for chromosome segregation during mitosis, but its functional mechanism during meiosis remains poorly understood. Oocyte microinjection, western blotting, co-immunoprecipitation, and immunofluorescence were used to explore the localization and function of centromere protein F in oocytes. The role of centromere protein F farnesylation in mouse oocytes was investigated using pharmacological (farnesyltransferase inhibitor treatment) and genetic (C3111S point mutation) methods. Subsequently, 4 patients with centromere protein F mutations were identified in the whole-exome sequencing dataset consisting of 179 infertile patients with oocyte maturation disorders. Mouse oocyte and 293T cell models were used to verify the mechanism of patient-derived centromere protein F mutations causing oocyte maturation disorders. RESULTS: Microinjection of centromere protein F siRNA into mouse oocytes significantly reduced maturation rates (77.84±2.087% vs 34.26±4.748%, P <.01), with the majority arrested at metaphase I (17.69±2.207% vs 44.93±5.539%, P <.05). Time-course immunofluorescence analysis revealed dynamic centromere protein F localization: initially dispersed across chromosome following nuclear envelope breakdown and then progressively accumulating at kinetochores by metaphase I. Co-immunoprecipitation assays confirmed a direct interaction between centromere protein F and Aurora kinase B. Knockdown of Aurora kinase B would damage the kinetochore localization of centromere protein F in oocytes. Farnesylation inhibition (via farnesyltransferase inhibitor or C3111S mutation) significantly decreased oocyte maturation rates (75.58±3.703% vs 46.18±1.282%, P <.01; 75.58±3.703% vs 44.04±2.541%, P <.01), concomitantly weakening interaction between centromere protein F and Aurora kinase B (P <.01) and disrupting kinetochore localization. Genetic screening identified 4 centromere protein F mutations in 179 infertile women with oocyte maturation arrest. Microinjection of patient-derived mutant centromere protein F complementary RNAs into mouse oocytes significantly reduced maturation rates (77.00±2.411% vs 49.10±6.561%, P <.01; 77.00±2.411% vs 35.43±1.035%, P <.01; 77.00±2.411% vs 55.43±1.288%, P <.05; 77.00±2.411% vs 40.00±4.187%, P <.01). Two of these mutations (K1708T/S1971fs) can reduce the farnesylation of centromere protein F (P <.05/P <.01), damage its interaction with Aurora kinase B (P <.05/P <.01), and disrupt the kinetochore localization. Both centromere protein F depletion and patient mutations induced constitutive spindle assembly checkpoint activation, and the treatment with spindle assembly checkpoint inhibitor partially rescued the meiotic arrest phenotype in oocytes (P <.05). CONCLUSION: This study represents the first demonstration of a direct association between centromere protein F genetic defects and human infertility, uncovering a novel farnesylation-dependent mechanism that governs meiotic progression, while simultaneously identifying centromere protein F as a potential molecular marker for diagnosing oocyte maturation failure.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Zhong O, Wang C, Zhang J, et al. Farnesylation-dependent kinetochore targeting of centromere protein F is essential for oocyte meiotic progression and female fertility. Am J Obstet Gynecol. 2025. PMID: 40885416. doi:10.1016/j.ajog.2025.08.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。